Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. SC 13D/A Stake Beneficial Ownership Report
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. PREC14A Other PREC14A
  4. DEFA14A Proxy Proxy Materials
  5. 8-K/A Event Executive or director change
  6. UPLOAD Other SEC-generated Letter
  7. 8-K Event Executive or director change
  8. SC 13G/A Stake Amended Statement of Ownership
  9. DEFA14A Proxy Proxy Materials
  10. SC TO-I Deal Tender Offer Statement by Issuer
  11. SC 13D Stake Beneficial Ownership Report
  12. 11-K Other Annual Report
  13. NO ACT Other No Action Letter
  14. NO ACT Other No Action Letter
  15. DEFA14A Proxy Proxy Materials
  16. 8-K Event Executive or director change
  17. PREM14A Deal PREM14A
  18. DEFA14A Proxy Proxy Materials
  19. 10-Q Report Quarterly Report
  20. DEFA14A Proxy Proxy Materials

Page 48 of 89 · 1,773 filings